Dr. Nelson completed his Bachelor’s Degree in Biological Engineering at the University of Arkansas, and his PhD from Vanderbilt University. Dr. Nelson is currently pursuing research at Duke University supported by The Hartwell Foundation Postdoctoral Fellowship and the prestigious NIH Pathway to Independence Award (K99/R00).
Dr. Nelson’s primary research interests are in developing new technologies for therapeutic genome engineering. Previously, he has developed biomaterial-based platforms for drug and gene delivery including a nanoparticle for systemic siRNA administration (ACS Nano 2013) and a multifunctional scaffold for local gene silencing for regenerative medicine (Advanced Materials 2014). More recently, he has applied a genome engineering approach to treat the genetic basis of Duchenne muscular dystrophy in vivo (Science 2016). Dr. Nelson now plans to apply gene and drug delivery to genome engineering to create precision molecular therapies, study regenerative medicine, and interrogate gene function and regulation.
Welcome, Dr. Nelson!